OMX Nordic 40
|
2 709,64
|
26,72
|
1,00 %
|
Analysen zu OMX Nordic 40-Werten
| 19.11.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 19.11.25 | ABB Sell | Deutsche Bank AG | |
| 19.11.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 19.11.25 | ABB Underperform | Bernstein Research | |
| 18.11.25 | ABB Sector Perform | RBC Capital Markets | |
| 18.11.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.11.25 | Novo Nordisk Neutral | UBS AG | |
| 18.11.25 | ABB Sector Perform | RBC Capital Markets | |
| 17.11.25 | ABB Sector Perform | RBC Capital Markets | |
| 14.11.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 12.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.11.25 | Novo Nordisk Neutral | UBS AG | |
| 11.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Novo Nordisk Halten | DZ BANK | |
| 10.11.25 | AstraZeneca Halten | DZ BANK | |
| 10.11.25 | Novo Nordisk Neutral | UBS AG | |
| 10.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 10.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Nokia Buy | Deutsche Bank AG | |
| 10.11.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 10.11.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 07.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 07.11.25 | AstraZeneca Buy | UBS AG | |
| 07.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 06.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.25 | AstraZeneca Buy | UBS AG | |
| 06.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.11.25 | Novo Nordisk Neutral | UBS AG | |
| 06.11.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 05.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 05.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.25 | Nokia Buy | Jefferies & Company Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
| Novo Nordisk | 5 |
| AstraZeneca | 4 |
| ABB | 4 |
| Nokia | 2 |
| Volvo AB | 2 |
| A.P. Moeller - Maersk A-S | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.